These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22016968)

  • 1. [Study on pharmacokinetics of HCPT nanosuspensions with ability of inhibiting P-gp in rats after oral administration].
    Pu X; Sun J; Zhang P; Wang Y; Sun Y; He Z
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1959-63. PubMed ID: 22016968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of a UPLC-MS/MS method for the pharmacokinetic study of 10-hydroxy camptothecin and hydroxyethyl starch conjugate in rats.
    Li G; Cai C; Ren T; Tang X
    J Pharm Biomed Anal; 2014 Jan; 88():345-53. PubMed ID: 24140449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a RP-HPLC method with fluorescence detection for simultaneous determination of 10-methoxycamptothecin and its metabolite 10-hydroxycamptothecin in rat plasma.
    Zheng J; Zhang R; Shao C; Hu Z; Wang D; Yu T; Yan X; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():81-7. PubMed ID: 22824730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a sensitive reversed-phase HPLC method to determine intracellular accumulation of hydroxycamptothecin.
    Zhao YX; Gao JQ; Qiao HL; Chen HL; Liang WQ
    J Pharm Biomed Anal; 2006 Jun; 41(3):1007-10. PubMed ID: 16497465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].
    Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG
    Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.
    Xing H; Luo X; Li Y; Fan C; Liu N; Cui C; Li W
    Pharm Biol; 2020 Dec; 58(1):152-156. PubMed ID: 31990625
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of 3,4-Dihydroxy Methyl Benzoate in Rat Plasma by HPLC and Its Pharmacokinetics.
    Jiang Z; Xu H; Zhao Y; Yu M
    J Chromatogr Sci; 2016 Feb; 54(2):144-7. PubMed ID: 26276846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
    Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue distribution study of 10-methoxycamptothecin in rats following intragastric administration.
    Zheng J; Ji Y; Shao C; Jing L; Wang Y
    J Pharm Biomed Anal; 2018 Feb; 149():564-571. PubMed ID: 29197298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of protocatechuic acid in rat plasma by high performance liquid chromatography].
    Han Y; Xiong Z; Yang C; Liu M; Li F
    Se Pu; 2007 Mar; 25(2):207-10. PubMed ID: 17580687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo imaging in tumor-bearing animals and pharmacokinetics of PEGylated liposomes modified with RGD cyclopeptide].
    Tu LX; Xu YH; Tang CY; Deng LH; Wu CB
    Yao Xue Xue Bao; 2012 May; 47(5):646-51. PubMed ID: 22812011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
    Wang AX; Li S; Ding XQ; Chen Y; Chen D
    Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
    Han M; Liu X; Guo Y; Wang Y; Wang X
    Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
    Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
    Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antitumor activity and pharmacokinetic study of 10-propionyloxy camptothecin in rats.
    Zheng J; Shao C; Fan B; Jing L; Li S; Yan X; Wang Y
    Biomed Chromatogr; 2018 Nov; 32(11):e4336. PubMed ID: 30003562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
    Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mangiferin in rat plasma after oral administration of a single dose of suanzaoren decoction.
    Li YJ; Bi KS
    Yao Xue Xue Bao; 2005 Feb; 40(2):164-7. PubMed ID: 15875675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic study of intraperitoneal chemotherapy with HCPT].
    Ye M; Lin XX; Pan HM; Li N; Lou F; Jin W; Zheng Y; Wu JM
    Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1610-2. PubMed ID: 16422545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF; Li K; Xu JH; Du Y; Zhang YF
    Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.